Search

The concentration of total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) were determined among students of PFUR aged 17-25, from different climatic and geographical regions. In all the concentrations (> 6.2 mmol/L) of total plasma cholesterol were detected at 6 (2.4%) students, indicating a high or very high risk of coronary heart disease (CHD). Elevated levels of plasma LDL-C (> 3.31 mmol/l) were found at 4 (1.6%) students, indicating a high or very high risk of coronary heart disease. Lower concentrations of HDL-C plasma (< 1.31 > 1.1 mmol/L) were detected at 30 (12.4%) indicating a moderate risk of CHD and at 11 (4.6%) students concentration of HDL-C were lower (1,1 mmol/L), indicating a high risk of coronary heart disease. The results can be used as a justification for the screening survey to identify dyslipidemia among adolescents and young adults, with the subsequent conducting of the individual preventive and therapeutic measures.

The concentrations of total cholesterol (CH) in the blood plasma were determined among 246 students of the PFUR. The students were divided into groups according to concentrations of total cholesterol: the “optimal” (CH < 4.4 mmol/l); borderline 4.4 < CH < 5.4 mmol/l); and high (CH > 5.4 mmol/l) for persons under the age of 20 years and young adults older than 20 years, which were accepted as independent risk factors for ischemic heart disease IHD. Borderline values of CH were detected in 19% of students, who require a deeper examination to identify additional risk factors for IHD. Among 5% of the examined students, high concentrations of CH were revealed. This group of students also needs further evaluation and deciding on the need for dietary and pharmacological correction of hypercholesterolemia.

Three follow-up single-stage standardized examinations for revealing of ischemic heart disease (IHD) were conducted among males at the age 50-59 with tuberculosis in 1972, 1998, 2011 years. The results of studies are conformed that prevalence of IHD among males with tuberculosis is not changed during this period and remained on relatively high level from 21.0-31.9%. Practically every 5th male with tuberculosis has clinical signs of IHD that could be considered as a support of necessity of joint simultaneous treatment of tuberculosis and IHD.